Galectin Therapeutics Inc - Çeyreklik Finansal İstatistikler (NASDAQ:GALT) | MetaTrader

Tam grafiği aç

Financials

Genel Bakış Tablolar İstatistikler

Çeyreklik Yıllık

İşletme faaliyetlerinden elde edilen nakit -12.79 M-7.69 M-6.6 M-3.54 M-6.04 M -23.88 M Yatırım faaliyetlerinden elde edilen nakit ————— — Finansman faaliyetlerinden elde edilen nakit 851 K012.94 M1.3 M12.24 M 26.48 M Free cash flow -12.79 M-7.69 M-6.6 M-3.54 M-6.04 M -23.88 M

Haberler

Galectin Therapeutics appoints Johns Hopkins neurosurgeon to board

Galectin Therapeutics Inc. (GALT) Discusses Updated Results for Belapectin in Treatment of MASH Cirrhosis and Portal Hypertension Transcript

Galectin Therapeutics yönetim kurulu üyesi Marc Rubin istifa etti

Galectin Therapeutics director Marc Rubin resigns from board

Galectin Therapeutics CFO’su 233 bin dolarlık hisse satışı gerçekleştirdi

Galectin Therapeutics CFO sells $233k in shares

Galectin Therapeutics: Runway With Convertible Financing But Dilution Overhang Remains

oracle, micron tech among market cap stock movers on friday

Galectin Therapeutics hisseleri FDA geri bildirimi sonrası sert düşüş yaşadı

Galectin Therapeutics stock plummets after FDA feedback on drug

FDA, Galectin’in belapectin geliştirme programı hakkında geri bildirim verdi

FDA provides feedback on Galectin’s belapectin development program